Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 7
2020 38
2021 16
2022 11
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
Tendler S, Dunphy MP, Agee M, O'Donoghue J, Aly RG, Choudhury NJ, Kesner A, Kirov A, Mauguen A, Baine MK, Schoder H, Weber WA, Rekhtman N, Lyashchenko SK, Bodei L, Morris MJ, Lewis JS, Rudin CM, Poirier JT. Tendler S, et al. medRxiv [Preprint]. 2024 Jan 11:2024.01.10.24301109. doi: 10.1101/2024.01.10.24301109. medRxiv. 2024. PMID: 38260492 Free PMC article. Preprint.
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model".
Ahad A, Saeed HK, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Ahad A, et al. ACS Pharmacol Transl Sci. 2024 Jan 3;7(1):298-299. doi: 10.1021/acsptsci.3c00364. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2024. PMID: 38230288 Free article.
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model.
Ahad A, K Saeed H, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. Ahad A, et al. ACS Pharmacol Transl Sci. 2023 Nov 22;6(12):1972-1986. doi: 10.1021/acsptsci.3c00270. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093840
PET and Optical Imaging of Caveolin-1 in Gastric Tumors.
Surendra Panikar S, Shmuel S, Lewis JS, Pereira PMR. Surendra Panikar S, et al. ACS Omega. 2023 Sep 15;8(39):35884-35892. doi: 10.1021/acsomega.3c03614. eCollection 2023 Oct 3. ACS Omega. 2023. PMID: 37810678 Free PMC article.
Click Chemistry and Radiochemistry: An Update.
Bauer D, Cornejo MA, Hoang TT, Lewis JS, Zeglis BM. Bauer D, et al. Bioconjug Chem. 2023 Nov 15;34(11):1925-1950. doi: 10.1021/acs.bioconjchem.3c00286. Epub 2023 Sep 22. Bioconjug Chem. 2023. PMID: 37737084 Free PMC article. Review.
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
Maron SB, Chatila W, Walch H, Chou JF, Ceglia N, Ptashkin R, Do RKG, Paroder V, Pandit-Taskar N, Lewis JS, Biachi De Castria T, Sabwa S, Socolow F, Feder L, Thomas J, Schulze I, Kim K, Elzein A, Bojilova V, Zatzman M, Bhanot U, Nagy RJ, Lee J, Simmons M, Segal M, Ku GY, Ilson DH, Capanu M, Hechtman JF, Merghoub T, Shah S, Schultz N, Solit DB, Janjigian YY. Maron SB, et al. Clin Cancer Res. 2023 Sep 15;29(18):3633-3640. doi: 10.1158/1078-0432.CCR-22-3769. Clin Cancer Res. 2023. PMID: 37406106 Free PMC article. Clinical Trial.
81 results